Portage Biotech Inc Ord (PRTG) Stock Price, Quote & News

Company Profile

Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline comprises PORT-8, a dual inhibitor of adenosine receptors 2A and 2B, which is in preclinical trial to treat solid tumors; PORT-9, an A2B antagonist, which is in pre-clinical stage program to treat colorectal and gastrointestinal cancers; and PORT-3, a polylactide-co-glycolide, which is in phase 1 to treat NY-ESO-1 positive tumors. Th...

Industry: Biotechnology

Sector: Healthcare

Phone: 203 221 7378

Website: www.portagebiotech.com

Address:

Clarence Thomas Building, P.O. Box 4649 Road Town, Tortola, British Virgin Islands

Stopcapping Jun. 16 at 6:04 PM

$PRTG Squeeze hard

0 · Reply

kerdni Jun. 13 at 5:51 AM

$PRTG https://convention.bio.org/exhibitors/portage-biotech

1 · Reply

kerdni Jun. 13 at 5:42 AM

$PRTG June 9 was nasdaq compliance date, yet no filings

0 · Reply

HectorNumba9 Jun. 12 at 5:55 PM

$PRTG Damn im jealous/the timing

0 · Reply

yft212 Jun. 11 at 4:59 PM

$SNWV So another stock I own is $PRTG and low and behold I find out this... https://www.stocktitan.net/news/PRTG/portage-biotech-and-compedica-stock-for-stock-1s4jrereh6kr.html https://compedica.com/

0 · Reply

YasirTrades Jun. 10 at 5:43 AM

GLMD more news! + big short interest , has Fast Track designation from the FDA, multiple Phase 3 results, and is now expanding into oncology + GLP 1 combos. Ran to $24 and can do it again. Meanwhile, shorts pay over 100% to borrow. $LOBO $PTIX $PRTG $LICN !!

0 · Reply

Stopcapping Jun. 6 at 1:29 PM

$PRTG say hi to the team!!

0 · Reply

Stopcapping Jun. 5 at 3:01 PM

$PRTG Super low volume 3000 is super small.Friday or AH today.$$$ time.

0 · Reply

papapumps Jun. 5 at 11:42 AM

$PRTG Time to unleash the Kraken !

0 · Reply

Stopcapping Jun. 4 at 11:36 PM

$PRTG Low volume raised it 12%.They’re getting ready to gap this up.High volume will gap this!!Play accordingly!!!

0 · Reply

Portage Biotech and Compedica Stock-for-Stock Exchange

Apr 28, 2025, 10:37 AM EDT - 7 weeks ago

Portage Biotech Stock Surges As It Prepares For Human Trial

Apr 28, 2025, 6:00 AM EDT - 7 weeks ago

Portage Biotech Reports Confirmatory Preclinical Results in Mesothelioma Supporting First-In-Human Trial of PORT-7

Mar 28, 2025, 1:13 PM EDT - 2 months ago

Why Is Portage Biotech Stock Skyrocketing Friday?

Mar 27, 2025, 6:02 PM EDT - 2 months ago

Portage Biotech Shares More Than Double After Results of PORT-7 Tumor Treatment Trial

Mar 12, 2025, 8:00 AM EDT - 3 months ago

Portage Biotech Resumes Enrollment in Final Cohort of Dose Escalation for Port-6 in ADPORT-601 Trial

Feb 12, 2025, 4:15 PM EST - 4 months ago

Portage Biotech Receives Extension of Time to Attain Compliance With Stock Exchange Continued Listing Requirements

Jan 30, 2025, 4:30 PM EST - 4 months ago

Portage Biotech Announces Completion of $2.15 Million Private Financing

Jan 6, 2025, 5:00 AM EST - 5 months ago

Portage Biotech Announce Re-Launch of Adenosine Subsidiary as Independently Managed Company; Appointment of Peter Molloy to Lead New Company

Dec 12, 2024, 4:15 PM EST - 6 months ago

Portage Biotech Announces Receipt of Nasdaq Noncompliance Letter

Nov 26, 2024, 4:05 PM EST - 7 months ago

Portage Biotech Reports Results for Fiscal Quarter Ended September 30, 2024

Apr 12, 2024, 8:01 AM EDT - 1 year ago

Portage Biotech Announces Plans to Expand its Evaluation of Strategic Alternatives

Mar 26, 2024, 8:01 AM EDT - 1 year ago

Portage Biotech Completes Monetization of Intensity Therapeutics (INTS) shares

Feb 28, 2024, 5:10 PM EST - 1 year ago

Portage Biotech Reports Results for Fiscal Quarter Ended December 31, 2023, and Business Update

Jan 4, 2024, 8:00 AM EST - 1 year ago

Portage Biotech Reports Business and Strategic Update

Nov 28, 2023, 4:01 PM EST - 1 year ago

Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023, and Business Update

Nov 6, 2023, 8:01 AM EST - 1 year ago

Portage Biotech Presents Updates on its iNKT and Adenosine programs at the Society for Immunotherapy of Cancer's (SITC) 38th Annual Meeting

Sep 29, 2023, 8:00 AM EDT - 1 year ago

Portage Biotech Announces $6.0 Million Registered Direct Offering

Sep 20, 2023, 8:00 AM EDT - 1 year ago

Portage Biotech to Participate in Panel Discussion at the Cantor Global Healthcare Conference

Sep 5, 2023, 8:00 AM EDT - 1 year ago

Portage Biotech Announces Collaboration with Merck to Evaluate Two Next-Generation Adenosine Antagonists in Combination with KEYTRUDA® (Pembrolizumab) in Solid Tumors

Aug 30, 2023, 8:00 AM EDT - 1 year ago

Portage Biotech Reports Results for Fiscal Quarter Ended June 30, 2023 and Business Update

Jul 31, 2023, 4:05 PM EDT - 2 years ago

Portage Biotech Reports Fiscal Year-Ended March 31, 2023 Financial Results and Business Update

Jun 26, 2023, 8:00 AM EDT - 2 years ago

Portage Biotech Announces First Patient Dosed in Phase 1a Trial of PORT-6 in Select Solid Tumors

Jun 5, 2023, 8:00 AM EDT - 2 years ago

Portage Biotech Reports Updated Interim Data for Lead iNKT Engager, PORT-2, in a Phase 1/2 Trial for the Treatment of Advanced Melanoma and Metastatic Non-Small Cell Lung Cancer at the 2023 American Society for Clinical Oncology (ASCO) Annual Meeting

Jun 1, 2023, 8:00 AM EDT - 2 years ago

Portage Biotech to Participate in Panel Discussion During the 2023 BIO International Conference

Apr 26, 2023, 5:00 PM EDT - 2 years ago

Portage Biotech Announces Upcoming PORT-2 Poster Presentation at the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting

Mar 7, 2023, 8:00 AM EST - 2 years ago

Portage Biotech to Present at Oppenheimer's 33rd Annual Healthcare Conference

Mar 1, 2023, 8:00 AM EST - 2 years ago

Portage Biotech Announces Results for Fiscal Quarter Ended December 31, 2022

Feb 27, 2023, 4:05 PM EST - 2 years ago

Portage Biotech Hosting Key Opinion Leader Event on Targeting the Adenosine Pathway in Cancer

Feb 15, 2023, 8:00 AM EST - 2 years ago

Portage Biotech to Participate in Citi's 2023 Virtual Oncology Leadership Summit

Nov 29, 2022, 4:43 PM EST - 2 years ago

Portage Biotech Announces Results for Fiscal Quarter Ended September 30, 2022

Nov 10, 2022, 9:00 AM EST - 2 years ago

Portage Biotech Presents Updated Data on the Phase 1/2 Trial Evaluating PORT-2 at the Society for Immunotherapy of Cancer's (SITC) 37th Annual Meeting

Nov 8, 2022, 8:00 AM EST - 2 years ago

Portage Biotech Announces Clinical Trial Collaboration Agreement with Merck

Sep 14, 2022, 8:39 AM EDT - 2 years ago

Portage Biotech Provides Research and Development Update

Sep 8, 2022, 8:00 AM EDT - 3 years ago

Portage Biotech to Present at Upcoming Investor Conferences

Aug 29, 2022, 8:00 AM EDT - 3 years ago

Portage Biotech Announces Results for Fiscal Quarter Ended June 30, 2022

Aug 18, 2022, 8:00 AM EDT - 3 years ago

Portage Biotech Announces Leadership Updates

Aug 1, 2022, 9:10 AM EDT - 3 years ago

UPDATE -- Portage Biotech Announces Results for Fiscal Year Ended March 31, 2022

Aug 1, 2022, 8:00 AM EDT - 3 years ago

Portage Biotech Announces Results for Fiscal Year Ended March 31, 2022

Jul 20, 2022, 4:07 PM EDT - 3 years ago

Portage Biotech Shares Gain On Buying Outstanding Minority Interest In iNKT Platform

Jul 20, 2022, 9:00 AM EDT - 3 years ago

Portage Biotech Acquires Outstanding Minority Interest of Invariant Natural Killer T cell (iNKT) Agonist Platform

Jul 6, 2022, 4:05 PM EDT - 3 years ago

Portage Biotech Bolsters Pipeline with Acquisition of Four Candidates Targeting the Adenosine Pathway

Jun 6, 2022, 8:00 AM EDT - 3 years ago

Portage Biotech Summarizes Data Presented at ASCO 2022 Annual Meeting Including Updates from Ongoing PORT-2 Study

Apr 25, 2022, 8:00 AM EDT - 3 years ago

Portage Biotech Enters Cooperative Research and Development Agreement with U.S. National Cancer Institute and Stimunity

Apr 13, 2022, 10:00 AM EDT - 3 years ago

Portage Biotech Highlights Promising Data Presented on STING-Activating Therapy, PORT-5 (STI-001) at AACR 2022 Annual Meeting

Mar 31, 2022, 8:00 AM EDT - 3 years ago

Portage Biotech Provides Update on Clinical-Stage and Development Programs

Mar 9, 2022, 9:00 AM EST - 3 years ago

Portage Biotech Announces Presentation of PORT-5 (STI-001) Late-Breaking Data at AACR 2022 Annual Meeting

Feb 24, 2022, 5:43 PM EST - 3 years ago

Portage Biotech Announces Financial Results and Provides Business Update for Third Quarter of 2022 Fiscal Year

Feb 15, 2022, 8:00 AM EST - 3 years ago

Portage Biotech Announces New Appointments to its Management Team and Board of Directors

Jan 5, 2022, 8:00 AM EST - 3 years ago

Portage Biotech Announces Participation in January 2022 Investor Conferences

Stopcapping Jun. 16 at 6:04 PM

$PRTG Squeeze hard

0 · Reply

kerdni Jun. 13 at 5:51 AM

$PRTG https://convention.bio.org/exhibitors/portage-biotech

1 · Reply

kerdni Jun. 13 at 5:42 AM

$PRTG June 9 was nasdaq compliance date, yet no filings

0 · Reply

HectorNumba9 Jun. 12 at 5:55 PM

$PRTG Damn im jealous/the timing

0 · Reply

yft212 Jun. 11 at 4:59 PM

$SNWV So another stock I own is $PRTG and low and behold I find out this... https://www.stocktitan.net/news/PRTG/portage-biotech-and-compedica-stock-for-stock-1s4jrereh6kr.html https://compedica.com/

0 · Reply

YasirTrades Jun. 10 at 5:43 AM

0 · Reply

Stopcapping Jun. 6 at 1:29 PM

$PRTG say hi to the team!!

0 · Reply

Stopcapping Jun. 5 at 3:01 PM

$PRTG Super low volume 3000 is super small.Friday or AH today.$$$ time.

0 · Reply

papapumps Jun. 5 at 11:42 AM

$PRTG Time to unleash the Kraken !

0 · Reply

Stopcapping Jun. 4 at 11:36 PM

$PRTG Low volume raised it 12%.They’re getting ready to gap this up.High volume will gap this!!Play accordingly!!!

0 · Reply

Stopcapping Jun. 4 at 10:36 PM

$PRTG Gap to 16 in coming Merger News! Huge investors stepping up!!⬆️

0 · Reply

Biotech_guy Jun. 4 at 8:55 PM

$PRTG something is brewing here at Portage. Volume is up, share price is up, sentiment is up. Approaching news.. 💫💥

0 · Reply

Sjpu Jun. 4 at 7:26 PM

$PRTG come here, $LIMN is about to pop, less than 200k free float and highly shorted- unreasonable naked shorting

0 · Reply

kshonstocks Jun. 4 at 3:51 PM

$PRTG hitting scans 50 dma turn up

0 · Reply

Samsn Jun. 2 at 11:01 PM

$PRTG can you please go up already? Been patient for few weeks

0 · Reply

HectorNumba9 May. 31 at 10:22 PM

$TOVX in $PRTG They bled same way and lately been pumping for og and new investors/traders as they continue science. $MCRB stayed held firm on penny price for awhile till was obvious they shoulda took a cheap BO/got greedy. No way Shallcross makes that mistake. He's talking to someone. Why would they want a partnership

1 · Reply

DaBullRunner May. 30 at 4:42 PM

$ALZN getting stupid cheap especially after they need This could be the next $PRTG $PTIX $DRUG and dare I say $RGC

1 · Reply

dbr_island May. 30 at 2:55 PM

$ALZN slowly adding as I think there’s a $PRTG type run coming Yesterday was just the appetizer The main course is coming next 🥩🍱🍴✅

0 · Reply

Stopcapping May. 30 at 12:19 AM

$PRTG Watch for gap up soon!!!

0 · Reply

HectorNumba9 May. 27 at 4:38 PM

$PRTG $20⏳

2 · Reply

Gregws May. 23 at 3:49 PM

$PRTG

1 · Reply

Stopcapping May. 23 at 1:09 PM

$PRTG 7.77 is that right 😂

0 · Reply

Market Cap	6.28M
Revenue (ttm)	0.00
Net Income (ttm)	-75.34M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	27,267
Avg Vol	1,027,262
Day's Range	N/A - N/A
Shares Out	1.05M
Stochastic %K	1%
Beta	0.33
Analysts	Strong Buy
Price Target	$140.00